FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3031447558> ?p ?o ?g. }

• W3031447558 abstract "Abstract Background Postoperative upper gastrointestinal fistula (PUGIF) is a devastating complication, leading to high mortality (reaching up to 80%), increased length of hospital stay, reduced health-related quality of life and increased health costs. Nutritional support is a key component of therapy in such cases, which is related to the high prevalence of malnutrition. In the prophylactic setting, enteral nutrition (EN) is associated with a shorter hospital stay, a lower incidence of severe infectious complications, lower severity of complications and decreased cost compared to total parenteral nutrition (TPN) following major upper gastrointestinal (GI) surgery. There is little evidence available for the curative setting after fistula occurrence. We hypothesize that EN increases the 30-day fistula closure rate in PUGIF, allowing better health-related quality of life without increasing the morbidity or mortality. Methods/design The NUTRILEAK trial is a multicenter, randomized, parallel-group, open-label phase III trial to assess the efficacy of EN (the experimental group) compared with TPN (the control group) in patients with PUGIF. The primary objective of the study is to compare EN versus TPN in the treatment of PUGIF (after esophagogastric resection including bariatric surgery, duodenojejunal resection or pancreatic resection with digestive tract violation) in terms of the 30-day fistula closure rate. Secondary objectives are to evaluate the 6-month postrandomization fistula closure rate, time of first fistula closure (in days), the medical- and surgical treatment-related complication rate at 6 months after randomization, the fistula-related complication rate at 6 months after randomization, the type and severity of early (30 days after randomization) and late fistula-related complications (over 30 days after randomization), 30-day and 6-month postrandomization mortality rate, nutritional status at day 30, day 60, day 90 and day 180 postrandomization, the mean length of hospital stay, the patient’s health-related quality of life (by self-assessment questionnaire), oral feeding time and direct costs of treatment. A total of 321 patients will be enrolled. Discussion The two nutritional supports are already used in daily practice, but most surgeons are reluctant to use the enteral route in case of PUGIF. This study will be the first randomized trial testing the role of EN versus TPN in PUGIF. Trial registration ClinicalTrials.gov: NCT03742752 . Registered on 14 November 2018." @default.
• W3031447558 created "2020-06-05" @default.
• W3031447558 creator A5000213748 @default.
• W3031447558 creator A5005205127 @default.
• W3031447558 creator A5006759849 @default.
• W3031447558 creator A5007825619 @default.
• W3031447558 creator A5009302310 @default.
• W3031447558 creator A5014886244 @default.
• W3031447558 creator A5016699090 @default.
• W3031447558 creator A5017870671 @default.
• W3031447558 creator A5017914629 @default.
• W3031447558 creator A5018385853 @default.
• W3031447558 creator A5018815717 @default.
• W3031447558 creator A5026700363 @default.
• W3031447558 creator A5030804869 @default.
• W3031447558 creator A5031805218 @default.
• W3031447558 creator A5035131168 @default.
• W3031447558 creator A5035516595 @default.
• W3031447558 creator A5039460996 @default.
• W3031447558 creator A5041054996 @default.
• W3031447558 creator A5041822261 @default.
• W3031447558 creator A5051252983 @default.
• W3031447558 creator A5053965371 @default.
• W3031447558 creator A5057040902 @default.
• W3031447558 creator A5058686770 @default.
• W3031447558 creator A5064621335 @default.
• W3031447558 creator A5070971840 @default.
• W3031447558 creator A5071791624 @default.
• W3031447558 creator A5079591293 @default.
• W3031447558 creator A5081229223 @default.
• W3031447558 creator A5086740707 @default.
• W3031447558 creator A5086872100 @default.
• W3031447558 creator A5087411743 @default.
• W3031447558 creator A5020604322 @default.
• W3031447558 date "2020-06-02" @default.
• W3031447558 modified "2023-10-17" @default.
• W3031447558 title "Enteral versus parenteral nutrition in the conservative treatment of upper gastrointestinal fistula after surgery: a multicenter, randomized, parallel-group, open-label, phase III study (NUTRILEAK study)" @default.
• W3031447558 cites W1544267971 @default.
• W3031447558 cites W1972538512 @default.
• W3031447558 cites W1974728202 @default.
• W3031447558 cites W1976783989 @default.
• W3031447558 cites W1978085179 @default.
• W3031447558 cites W2005523764 @default.
• W3031447558 cites W2018596338 @default.
• W3031447558 cites W2039485331 @default.
• W3031447558 cites W2041508751 @default.
• W3031447558 cites W2043167210 @default.
• W3031447558 cites W2052074628 @default.
• W3031447558 cites W2058503195 @default.
• W3031447558 cites W2066389333 @default.
• W3031447558 cites W2077295931 @default.
• W3031447558 cites W2081710964 @default.
• W3031447558 cites W2083469409 @default.
• W3031447558 cites W2096998881 @default.
• W3031447558 cites W2098486084 @default.
• W3031447558 cites W2099093564 @default.
• W3031447558 cites W2121834684 @default.
• W3031447558 cites W2130888802 @default.
• W3031447558 cites W2147806472 @default.
• W3031447558 cites W2166356134 @default.
• W3031447558 cites W2171811563 @default.
• W3031447558 cites W2223878258 @default.
• W3031447558 cites W2401439234 @default.
• W3031447558 cites W2464215942 @default.
• W3031447558 doi "https://doi.org/10.1186/s13063-020-04366-3" @default.
• W3031447558 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7265255" @default.
• W3031447558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32487210" @default.
• W3031447558 hasPublicationYear "2020" @default.
• W3031447558 type Work @default.
• W3031447558 sameAs 3031447558 @default.
• W3031447558 citedByCount "4" @default.
• W3031447558 countsByYear W30314475582020 @default.
• W3031447558 countsByYear W30314475582021 @default.
• W3031447558 countsByYear W30314475582022 @default.
• W3031447558 countsByYear W30314475582023 @default.
• W3031447558 crossrefType "journal-article" @default.
• W3031447558 hasAuthorship W3031447558A5000213748 @default.
• W3031447558 hasAuthorship W3031447558A5005205127 @default.
• W3031447558 hasAuthorship W3031447558A5006759849 @default.
• W3031447558 hasAuthorship W3031447558A5007825619 @default.
• W3031447558 hasAuthorship W3031447558A5009302310 @default.
• W3031447558 hasAuthorship W3031447558A5014886244 @default.
• W3031447558 hasAuthorship W3031447558A5016699090 @default.
• W3031447558 hasAuthorship W3031447558A5017870671 @default.
• W3031447558 hasAuthorship W3031447558A5017914629 @default.
• W3031447558 hasAuthorship W3031447558A5018385853 @default.
• W3031447558 hasAuthorship W3031447558A5018815717 @default.
• W3031447558 hasAuthorship W3031447558A5020604322 @default.
• W3031447558 hasAuthorship W3031447558A5026700363 @default.
• W3031447558 hasAuthorship W3031447558A5030804869 @default.
• W3031447558 hasAuthorship W3031447558A5031805218 @default.
• W3031447558 hasAuthorship W3031447558A5035131168 @default.
• W3031447558 hasAuthorship W3031447558A5035516595 @default.
• W3031447558 hasAuthorship W3031447558A5039460996 @default.
• W3031447558 hasAuthorship W3031447558A5041054996 @default.
• W3031447558 hasAuthorship W3031447558A5041822261 @default.
• W3031447558 hasAuthorship W3031447558A5051252983 @default.
• W3031447558 hasAuthorship W3031447558A5053965371 @default.
• W3031447558 hasAuthorship W3031447558A5057040902 @default.
• W3031447558 hasAuthorship W3031447558A5058686770 @default.

• next